Page last updated: 2024-10-25

dantrolene and Benign Neoplasms

dantrolene has been researched along with Benign Neoplasms in 1 studies

Dantrolene: Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.
dantrolene : The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. A ryanodine receptor antagonist used for the relief of chronic severe spasticity and malignant hyperthermia.

Research Excerpts

ExcerptRelevanceReference
"Eleven patients with various cancer types from ten case reports published from 1988 to 2013 met the eligibility criteria."2.66Neuroleptic malignant syndrome in patients with cancer: a systematic review. ( Ishida, M; Kawakami, K; Kawanishi, C; Onishi, H; Sato, I; Yamada, S, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Sato, I1
Onishi, H1
Kawanishi, C1
Yamada, S1
Ishida, M1
Kawakami, K1

Reviews

1 review available for dantrolene and Benign Neoplasms

ArticleYear
Neuroleptic malignant syndrome in patients with cancer: a systematic review.
    BMJ supportive & palliative care, 2020, Volume: 10, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Dantrolene; Dopamine D2 Receptor Antagonists;

2020